We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Devicemakers: FDA Manipulated Panel to Keep Depression Therapy in Class III
Devicemakers: FDA Manipulated Panel to Keep Depression Therapy in Class III
April 6, 2012
Makers of cranial electrotherapy stimulators (CES) are crying foul in the wake of an FDA advisory panel meeting that ruled against reclassifying the devices.